China Pharma extends convertible note maturity to Aug. 2025; minimum monthly payment cut 75%

CHINA PHARMA HOLDINGS, INC.

Maturity date of $557,735 convertible note (Streeterville Capital) extended to August 19, 2025.
Extension fee equal to 2% of outstanding balance added to principal; balance post-fee is $557,735.
Minimum monthly redemption amount reduced from $150,000 to $37,182.33 per month.
Original note principal was $5,250,000 issued November 2021; prior amendment in April 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.